Correction to: Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients
Cancer Immunology, Immunotherapy · 10.06.2026 · 75 (6)
DOI: 10.1007/s00262-026-04445-5 ↗Kurz gefasst
Korrektur in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 10.06.2026. Verfasst von Lingling Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth School of Clinical Medicine, Affiliated Zhejiang Chinese Medical University, Zhejiang, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- The Fourth School of Clinical Medicine, Affiliated Zhejiang Chinese Medical University, Zhejiang, People's Republic of China.
- Department of Translational Medicine Research Center, School of Medicine, Affiliated Hangzhou First People's Hospital, Westlake University, Hangzhou, People's Republic of China.
- Department of Thoracic Oncology, Affiliated Hangzhou Cancer Hospital, Zhejiang Chinese Medical University, No. 34, Yanguan Lane, Hangzhou, 310002, People's Republic of China.
- Department of Thoracic Oncology, Affiliated Hangzhou Cancer Hospital, Zhejiang Chinese Medical University, No. 34, Yanguan Lane, Hangzhou, 310002, People's Republic of China. zhulucheng1@zuaa.zju.edu.cn.
Zitieren
APA
Wang, L., Xu, Y., Zhao, Y., Xia, B., & Zhu, L. (2026). Correction to: Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients. Cancer Immunology, Immunotherapy, 75(6). https://doi.org/10.1007/s00262-026-04445-5
Vancouver
Wang L, Xu Y, Zhao Y, Xia B, Zhu L. Correction to: Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients. Cancer Immunology, Immunotherapy. 2026;75(6). doi:10.1007/s00262-026-04445-5
BibTeX
@article{Wang2026,
author = {Wang, Lingling and Xu, Yasi and Zhao, Yanyan and Xia, Bing and Zhu, Lucheng},
title = {Correction to: Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients},
journal = {Cancer Immunology, Immunotherapy},
year = {2026},
volume = {75},
number = {6},
doi = {10.1007/s00262-026-04445-5}
}
EUVIMED